Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols
- PMID: 10508281
- DOI: 10.1002/(sici)1522-2586(199909)10:3<223::aid-jmri2>3.0.co;2-s
Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols
Abstract
We describe a standard set of quantity names and symbols related to the estimation of kinetic parameters from dynamic contrast-enhanced T(1)-weighted magnetic resonance imaging data, using diffusable agents such as gadopentetate dimeglumine (Gd-DTPA). These include a) the volume transfer constant K(trans) (min(-1)); b) the volume of extravascular extracellular space (EES) per unit volume of tissue v(e) (0 < v(e) < 1); and c) the flux rate constant between EES and plasma k(ep) (min(-1)). The rate constant is the ratio of the transfer constant to the EES (k(ep) = K(trans)/v(e)). Under flow-limited conditions K(trans) equals the blood plasma flow per unit volume of tissue; under permeability-limited conditions K(trans) equals the permeability surface area product per unit volume of tissue. We relate these quantities to previously published work from our groups; our future publications will refer to these standardized terms, and we propose that these be adopted as international standards.
Similar articles
-
Modeling tracer kinetics in dynamic Gd-DTPA MR imaging.J Magn Reson Imaging. 1997 Jan-Feb;7(1):91-101. doi: 10.1002/jmri.1880070113. J Magn Reson Imaging. 1997. PMID: 9039598 Review.
-
Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters.AJR Am J Roentgenol. 2007 Oct;189(4):849. doi: 10.2214/AJR.06.1329. AJR Am J Roentgenol. 2007. PMID: 17885055
-
Flow versus permeability weighting in estimating the forward volumetric transfer constant (Ktrans) obtained by DCE-MRI with contrast agents of differing molecular sizes.Magn Reson Imaging. 2017 Feb;36:105-111. doi: 10.1016/j.mri.2016.10.027. Epub 2016 Oct 28. Magn Reson Imaging. 2017. PMID: 27989901
-
Pancreatic cancer: utility of dynamic contrast-enhanced MR imaging in assessment of antiangiogenic therapy.Radiology. 2010 Aug;256(2):441-9. doi: 10.1148/radiol.10091733. Epub 2010 Jun 1. Radiology. 2010. PMID: 20515976 Clinical Trial.
-
Classic models for dynamic contrast-enhanced MRI.NMR Biomed. 2013 Aug;26(8):1004-27. doi: 10.1002/nbm.2940. Epub 2013 May 15. NMR Biomed. 2013. PMID: 23674304 Review.
Cited by
-
Correlations of tumour permeability parameters with apparent diffusion coefficient in nasopharyngeal carcinoma.Phys Imaging Radiat Oncol. 2022 Sep 12;24:30-35. doi: 10.1016/j.phro.2022.09.001. eCollection 2022 Oct. Phys Imaging Radiat Oncol. 2022. PMID: 36148154 Free PMC article.
-
Magnetic resonance imaging biomarkers in hepatocellular carcinoma: association with response and circulating biomarkers after sunitinib therapy.J Hematol Oncol. 2013 Jul 10;6:51. doi: 10.1186/1756-8722-6-51. J Hematol Oncol. 2013. PMID: 23842041 Free PMC article. Clinical Trial.
-
Feasibility Study of EndoTAG-1, a Tumor Endothelial Targeting Agent, in Combination with Paclitaxel followed by FEC as Induction Therapy in HER2-Negative Breast Cancer.PLoS One. 2016 Jul 25;11(7):e0154009. doi: 10.1371/journal.pone.0154009. eCollection 2016. PLoS One. 2016. PMID: 27454930 Free PMC article. Clinical Trial.
-
A mechanistic compartmental model for total antibody uptake in tumors.J Theor Biol. 2012 Dec 7;314:57-68. doi: 10.1016/j.jtbi.2012.08.034. Epub 2012 Sep 6. J Theor Biol. 2012. PMID: 22974563 Free PMC article.
-
Quantitative analysis of 3-Tesla magnetic resonance imaging in the differential diagnosis of breast lesions.Exp Ther Med. 2015 Mar;9(3):913-918. doi: 10.3892/etm.2014.2154. Epub 2014 Dec 22. Exp Ther Med. 2015. PMID: 25667653 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous